SCHEMBL25820145

SCHEMBL25820145

Cc1cc(CC(C)C)c2cc(N3CCOC(C)C3)ccc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.38
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
CDK6 Q00534 1/20 0.37
NCF1 P14598 1/20 0.36
MAP3K7 O43318 2/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDPK1 O15530 1/20 0.35
LRRK2 Q5S007 2/20 0.35
MAPT P10636 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820144 0.87 NPSR1 (0.48) TSHRNPSR1KMT2AKDM4EMEN1
SCHEMBL25820175 0.84 KMT2A (0.49) TSHRNCF1POLBKMT2AKDM4E
SCHEMBL25820149 0.84 LRRK2 (0.39) SYKCDK4CCND1CDK6PDPK1
SCHEMBL25826546 0.81 LMNA (0.46) SYKTSHRNPSR1NCF1MAP3K7
SCHEMBL25821152 0.81 NCF1 (0.47) TSHRNCF1POLBKMT2AKDM4E
SCHEMBL25820102 0.81 NCF1 (0.41) NCF1KMT2AKDM4EMEN1ALDH1A1
SCHEMBL25820170 0.81 NCF1 (0.44) NCF1KMT2AKDM4EMEN1ALDH1A1
SCHEMBL25820157 0.79 TSHR (0.35) TSHRNPSR1MAP3K7MTOR
SCHEMBL25820146 0.79 LATS1 (0.37) SYKTSHRNCF1MAP3K7POLB
SCHEMBL25821148 0.75 MAPT (0.34) TSHRNCF1POLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR SYK 1886/4885TSHR 2571/4885NPSR1 4243/4885
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA SYK 1923/4885TSHR 2696/4885NPSR1 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.